Company Data
Context Therapeutics Inc.
Ticker
CNTX
Current Price
$0.6701
Market Cap
$60.1M
Price Target
Refer to Report
Volume
53.8K
52wk Range
$0.49 - $2.75
Overview
Context Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to improving the lives of women living with cancer. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer.